- Home
- KGEI vs DERM Comparison
KGEI vs DERM Comparison
Compare KGEI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- DERM
- Stock Information
- Founded
- KGEI 2008
- DERM 2014
- Country
- KGEI United States
- DERM United States
- Employees
- KGEI N/A
- DERM N/A
- Industry
- KGEI
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- KGEI
- DERM Health Care
- Exchange
- KGEI Nasdaq
- DERM Nasdaq
- Market Cap
- KGEI 163.1M
- DERM 190.7M
- IPO Year
- KGEI N/A
- DERM 2021
- Fundamental
- Price
- KGEI $4.61
- DERM $7.56
- Analyst Decision
- KGEI Strong Buy
- DERM Strong Buy
- Analyst Count
- KGEI 1
- DERM 3
- Target Price
- KGEI $11.00
- DERM $12.67
- AVG Volume (30 Days)
- KGEI 77.1K
- DERM 135.8K
- Earning Date
- KGEI 11-11-2025
- DERM 11-11-2025
- Dividend Yield
- KGEI N/A
- DERM N/A
- EPS Growth
- KGEI 35.27
- DERM N/A
- EPS
- KGEI 0.54
- DERM N/A
- Revenue
- KGEI $57,936,000.00
- DERM $56,397,000.00
- Revenue This Year
- KGEI $14.07
- DERM $26.16
- Revenue Next Year
- KGEI $26.69
- DERM $45.27
- P/E Ratio
- KGEI $8.41
- DERM N/A
- Revenue Growth
- KGEI 6.52
- DERM N/A
- 52 Week Low
- KGEI $2.91
- DERM $3.54
- 52 Week High
- KGEI $9.89
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- KGEI 32.74
- DERM 53.79
- Support Level
- KGEI $4.29
- DERM $7.05
- Resistance Level
- KGEI $4.80
- DERM $7.72
- Average True Range (ATR)
- KGEI 0.19
- DERM 0.32
- MACD
- KGEI -0.06
- DERM 0.02
- Stochastic Oscillator
- KGEI 22.70
- DERM 61.25
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.